ArticleBMC microbiology2025
Strain-specific interspecies interactions between co-isolated pairs of Staphylococcus aureus and Helcococcus kunzii from chronic wounds.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBacterial infection is major contributor in the delay of wound healing and persistence of non-healing wounds. Bacteria, functioning within complex multicellular communities, facilitate the survival of certain microorganisms in diverse environments. Helcococcus kunzii, a Gram-positive anaerobic commensal coccus, and Staphylococcus aureus, the primary pathogen in chronic wounds, have strong interaction potential, in which H. kunzii decreases the virulence of S. aureus in co-culture in vivo and in vitro.
resultsThis paper describes the interaction between H. kunzii and S. aureus clinical strains from chronic wounds by examining their transcriptomic behavior (S. aureus virulence genes) and phenotypic features (hemolysin production, growth and biofilm formation). We used five new clinical pairs of H. kunzii and S. aureus strains co-isolated from diabetic foot ulcers (DFU) and one previously studied clinical pair, not co-isolated from the same DFU. H. kunzii strains were sequenced and compared with two H. kunzii strains previously sequenced with high (H13) or low (H10) impact on S. aureus regulatory virulence effectors. Sequencing showed that all strains were phylogenetically similar to H13, with the exception of NHKT2, allowing to predict a potential "high impact" on S. aureus virulence. After coculture of clinical strain pairs in medium reflective of a chronic wound environment, we observed a downregulation of agrA and hla, two regulatory and virulence genes of S. aureus, supporting previously results obtained with not co-isolated strains. We confirmed a decrease in S. aureus hemolysin production in cocultures. While coculture did not affect the growth of S. aureus, the presence of H. kunzii appeared to influence the dynamics of S. aureus biofilm formation. Specifically, we noted a significant increase in S. aureus biofilm formation in coculture compared to monoculture during the biofilm maturation stage (after 72 h) for 4/5 of the co-isolated pairs.
conclusionsThe effect of reducing the virulence of S. aureus by H. kunzii described previously is not reproducible with co-isolated strains from same DFU. The therapeutic strategy of using H. kunzii as a probiotic should be reconsidered in favor of an approach that targets the underlying mechanisms responsible for this virulence reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.